X-155279223-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001289.6(CLIC2):āc.508A>Gā(p.Arg170Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000678 in 1,208,633 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 47 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000036 ( 0 hom., 2 hem., cov: 23)
Exomes š: 0.000071 ( 0 hom. 45 hem. )
Consequence
CLIC2
NM_001289.6 missense
NM_001289.6 missense
Scores
3
14
Clinical Significance
Conservation
PhyloP100: 3.79
Genes affected
CLIC2 (HGNC:2063): (chloride intracellular channel 2) This gene encodes a chloride intracellular channel protein. Chloride channels are a diverse group of proteins that regulate fundamental cellular processes including stabilization of cell membrane potential, transepithelial transport, maintenance of intracellular pH, and regulation of cell volume. This protein plays a role in inhibiting the function of ryanodine receptor 2. A mutation in this gene is the cause of an X-linked form of cognitive disability. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.044412732).
BS2
High Hemizygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLIC2 | NM_001289.6 | c.508A>G | p.Arg170Gly | missense_variant | 5/6 | ENST00000369449.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLIC2 | ENST00000369449.7 | c.508A>G | p.Arg170Gly | missense_variant | 5/6 | 1 | NM_001289.6 | P1 | |
CLIC2 | ENST00000321926.4 | c.382A>G | p.Arg128Gly | missense_variant | 4/4 | 3 | |||
CLIC2 | ENST00000465553.5 | n.623A>G | non_coding_transcript_exon_variant | 5/7 | 3 | ||||
CLIC2 | ENST00000491205.1 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111645Hom.: 0 Cov.: 23 AF XY: 0.0000591 AC XY: 2AN XY: 33821
GnomAD3 genomes
AF:
AC:
4
AN:
111645
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33821
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000136 AC: 25AN: 183204Hom.: 0 AF XY: 0.000207 AC XY: 14AN XY: 67710
GnomAD3 exomes
AF:
AC:
25
AN:
183204
Hom.:
AF XY:
AC XY:
14
AN XY:
67710
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000711 AC: 78AN: 1096935Hom.: 0 Cov.: 29 AF XY: 0.000124 AC XY: 45AN XY: 362305
GnomAD4 exome
AF:
AC:
78
AN:
1096935
Hom.:
Cov.:
29
AF XY:
AC XY:
45
AN XY:
362305
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111698Hom.: 0 Cov.: 23 AF XY: 0.0000590 AC XY: 2AN XY: 33884
GnomAD4 genome
AF:
AC:
4
AN:
111698
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33884
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
17
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.508A>G (p.R170G) alteration is located in exon 5 (coding exon 5) of the CLIC2 gene. This alteration results from a A to G substitution at nucleotide position 508, causing the arginine (R) at amino acid position 170 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
P;.
Vest4
MutPred
Loss of solvent accessibility (P = 0.0092);.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at